Limits...
Nuclear Medicine in Thyroid Diseases in Pediatric and Adolescent Patients.

Volkan-Salancı B, Kıratlı PÖ - Mol Imaging Radionucl Ther (2015)

Bottom Line: Use of radioactivity in pediatric population is strictly controlled due to possible side effects such as secondary cancers; therefore, management of pediatric patients requires detailed literature knowledge.This article aims to overview current algorithms in the management of thyroid diseases and use of radionuclide therapy in pediatric and adolescent population.Abstract available from the publisher.

View Article: PubMed Central - PubMed

Affiliation: Hacettepe University Faculty of Medicine, Department of Nuclear Medicine, Ankara, Turkey Phone: +90 312 305 13 36 E-mail: pkiratli@hacettepe.edu.tr.

ABSTRACT
Both benign and malignant diseases of the thyroid are rare in the pediatric and adolescent population, except congenital hypothyroidism. Nuclear medicine plays a major role, both in the diagnosis and therapy of thyroid pathologies. Use of radioactivity in pediatric population is strictly controlled due to possible side effects such as secondary cancers; therefore, management of pediatric patients requires detailed literature knowledge. This article aims to overview current algorithms in the management of thyroid diseases and use of radionuclide therapy in pediatric and adolescent population.

No MeSH data available.


Related in: MedlinePlus

Thyroid scintigraphy revealing thyroid agenesis in a 6 month-old boy (A), increased Tc-99m O4 uptake in the enlarged thyroid gland in a one month-old boy with documented hydrogen peroxide generation defect (B)
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4563170&req=5

f2: Thyroid scintigraphy revealing thyroid agenesis in a 6 month-old boy (A), increased Tc-99m O4 uptake in the enlarged thyroid gland in a one month-old boy with documented hydrogen peroxide generation defect (B)

Mentions: Thyroid hypoplasia is a less common diagnosis where radionuclide uptake is decreased and a smaller gland is identified on US. The diagnosis of thyroid agenesis is verified when the gland is not visualized with US or TS (Figure 2A).


Nuclear Medicine in Thyroid Diseases in Pediatric and Adolescent Patients.

Volkan-Salancı B, Kıratlı PÖ - Mol Imaging Radionucl Ther (2015)

Thyroid scintigraphy revealing thyroid agenesis in a 6 month-old boy (A), increased Tc-99m O4 uptake in the enlarged thyroid gland in a one month-old boy with documented hydrogen peroxide generation defect (B)
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4563170&req=5

f2: Thyroid scintigraphy revealing thyroid agenesis in a 6 month-old boy (A), increased Tc-99m O4 uptake in the enlarged thyroid gland in a one month-old boy with documented hydrogen peroxide generation defect (B)
Mentions: Thyroid hypoplasia is a less common diagnosis where radionuclide uptake is decreased and a smaller gland is identified on US. The diagnosis of thyroid agenesis is verified when the gland is not visualized with US or TS (Figure 2A).

Bottom Line: Use of radioactivity in pediatric population is strictly controlled due to possible side effects such as secondary cancers; therefore, management of pediatric patients requires detailed literature knowledge.This article aims to overview current algorithms in the management of thyroid diseases and use of radionuclide therapy in pediatric and adolescent population.Abstract available from the publisher.

View Article: PubMed Central - PubMed

Affiliation: Hacettepe University Faculty of Medicine, Department of Nuclear Medicine, Ankara, Turkey Phone: +90 312 305 13 36 E-mail: pkiratli@hacettepe.edu.tr.

ABSTRACT
Both benign and malignant diseases of the thyroid are rare in the pediatric and adolescent population, except congenital hypothyroidism. Nuclear medicine plays a major role, both in the diagnosis and therapy of thyroid pathologies. Use of radioactivity in pediatric population is strictly controlled due to possible side effects such as secondary cancers; therefore, management of pediatric patients requires detailed literature knowledge. This article aims to overview current algorithms in the management of thyroid diseases and use of radionuclide therapy in pediatric and adolescent population.

No MeSH data available.


Related in: MedlinePlus